This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: No defined compartments |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ClinicalUseDefinition.
Generated Narrative: ClinicalUseDefinition
Resource ClinicalUseDefinition "example"
type: contraindication
contraindication
DiseaseSymptomProcedures
- Concept * Hepatic disease associated with coagulopathy and clinically relevant bleeding risk (contraindicationsasdisease-symptom-procedure#Coagulopathiesandbleedingdiatheses(exclthrombocytopenic)) Comorbidities
- Concept * Hepaticdisease (comorbidity#Hepaticdisease)
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.